BML INC

BML, Inc. provides laboratory testing and related services in Japan. The company offers various tests, including biochemical, hematologic, and microbiological analysis. It also develops automation systems for pre-processing and testing procedures. Services include medical information system management, preventive medicine, and food sanitation testing. Environmental hygiene testing and biological dioxin monitoring are also provided. Additionally, the company offers analysis services for residual agricultural chemicals, dental tests, and consulting services. Founded in 1955, BML is headquartered in Tokyo, Japan.

Overview

Sector

Healthcare

Target Price

1595.0 JPY

Current Price

3305.0 JPY

Potential

-52%

Strengths

Price to book ratio (1.02) is lower than the sector mean (9.96).
The company is well capitalized. The company has net cash and no outstanding debt.
EV/EBITDA (3.66) is lower than the sector mean (36.02).
EV/EBIT (6.23) is lower than the sector mean.

Weaknesses

With a depreciation Potential of -46.61%, based on our fundamental analysis, it suggests the stock may be overvalued.

Key Financial Data

Indicator	Value
PER	20.6
EV/EBITDA	3.7
Price/Free Cash Flow'	100.0
ROIC	11.7%
Net Debt/EBITDA	-3.5